Functional genomic analysis of the response of HIV-1-infected lymphatic tissue to antiretroviral therapy - PubMed (original) (raw)
. 2004 Feb 15;189(4):572-82.
doi: 10.1086/381396. Epub 2004 Feb 5.
Affiliations
- PMID: 14767808
- DOI: 10.1086/381396
Functional genomic analysis of the response of HIV-1-infected lymphatic tissue to antiretroviral therapy
Qingsheng Li et al. J Infect Dis. 2004.
Abstract
Highly active antiretroviral therapy (HAART) curtails human immunodeficiency virus type 1 (HIV-1) replication in lymphatic tissues and partially reverses the pathological damage associated with infection, but the genes that mediate these pathological and reparative processes remain largely unknown. To identify these genes, we used microarrays to profile gene expression in serial lymph node biopsy specimens obtained before and after treatment. We discovered approximately 200 treatment-responsive genes, many of them known mediators and moderators of immune activation and defenses, particularly innate defense genes, which, surprisingly, were expressed at all stages of HIV-1 infection. Most of the rest of the treatment-responsive genes we categorized as mediators of trafficking, reformation of active follicles, and tissue repair. We propose a model in which nearly counterbalanced functions of mediators and moderators of immune activation and defenses account for the slow dynamics of HIV-1 infection before treatment. This model suggests that there could be a role for anti-inflammatory agents, alone or in combination with HAART, in treating HIV-1 infection by tipping this balance to mitigate pathology.
Comment in
- HIV-1 infection and genomics: sorting out the complexity.
Pomerantz RJ. Pomerantz RJ. J Infect Dis. 2004 Feb 15;189(4):567-71. doi: 10.1086/381398. Epub 2004 Feb 5. J Infect Dis. 2004. PMID: 14767807 Review. No abstract available.
Similar articles
- Potential roles of follicular dendritic cell-associated osteopontin in lymphoid follicle pathology and repair and in B cell regulation in HIV-1 and SIV infection.
Li Q, Lifson JD, Duan L, Schacker TW, Reilly C, Carlis J, Estes JD, Haase AT. Li Q, et al. J Infect Dis. 2005 Oct 1;192(7):1269-76. doi: 10.1086/444430. Epub 2005 Aug 25. J Infect Dis. 2005. PMID: 16136472 - Monitoring responses to antiretroviral treatment in human immunodeficiency virus type 1 (HIV-1)-infected patients by serial lymph node aspiration.
Bürgisser P, Spertini F, Weyrich-Suter C, Pagani JL, Meylan PR. Bürgisser P, et al. J Infect Dis. 1997 May;175(5):1202-5. doi: 10.1086/593568. J Infect Dis. 1997. PMID: 9129086 Clinical Trial. - Greater diversity of HIV DNA variants in the rectum compared to variants in the blood in patients without HAART.
Avettand-Fenoel V, Hocqueloux L, Müller-Trutwin M, Prazuck T, Melard A, Chaix ML, Agoute E, Michau C, Rouzioux C. Avettand-Fenoel V, et al. J Med Virol. 2011 Sep;83(9):1499-507. doi: 10.1002/jmv.22132. J Med Virol. 2011. PMID: 21739438 - Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues.
Haase AT. Haase AT. Annu Rev Immunol. 1999;17:625-56. doi: 10.1146/annurev.immunol.17.1.625. Annu Rev Immunol. 1999. PMID: 10358770 Review. - Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies.
Cohen OJ, Pantaleo G, Lam GK, Fauci AS. Cohen OJ, et al. Springer Semin Immunopathol. 1997;18(3):305-22. doi: 10.1007/BF00813500. Springer Semin Immunopathol. 1997. PMID: 9089951 Review.
Cited by
- T-cell exhaustion in HIV infection.
Fenwick C, Joo V, Jacquier P, Noto A, Banga R, Perreau M, Pantaleo G. Fenwick C, et al. Immunol Rev. 2019 Nov;292(1):149-163. doi: 10.1111/imr.12823. Immunol Rev. 2019. PMID: 31883174 Free PMC article. Review. - Gene-expression profiling of HIV-1 infection and perinatal transmission in Botswana.
Montano M, Rarick M, Sebastiani P, Brinkmann P, Russell M, Navis A, Wester C, Thior I, Essex M. Montano M, et al. Genes Immun. 2006 Jun;7(4):298-309. doi: 10.1038/sj.gene.6364297. Epub 2006 May 4. Genes Immun. 2006. PMID: 16691187 Free PMC article. - The immunosuppressive role of IL-32 in lymphatic tissue during HIV-1 infection.
Smith AJ, Toledo CM, Wietgrefe SW, Duan L, Schacker TW, Reilly CS, Haase AT. Smith AJ, et al. J Immunol. 2011 Jun 1;186(11):6576-84. doi: 10.4049/jimmunol.1100277. Epub 2011 Apr 27. J Immunol. 2011. PMID: 21525393 Free PMC article. - Genome-wide analysis of primary peripheral blood mononuclear cells from HIV + patients-pre-and post- HAART show immune activation and inflammation the main drivers of host gene expression.
da Conceicao VN, Dyer WB, Gandhi K, Gupta P, Saksena NK. da Conceicao VN, et al. Mol Cell Ther. 2014 Apr 3;2:11. doi: 10.1186/2052-8426-2-11. eCollection 2014. Mol Cell Ther. 2014. PMID: 26056580 Free PMC article. - Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons.
Tilton JC, Johnson AJ, Luskin MR, Manion MM, Yang J, Adelsberger JW, Lempicki RA, Hallahan CW, McLaughlin M, Mican JM, Metcalf JA, Iyasere C, Connors M. Tilton JC, et al. J Virol. 2006 Dec;80(23):11486-97. doi: 10.1128/JVI.00324-06. Epub 2006 Sep 27. J Virol. 2006. PMID: 17005663 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- K24 AI 56986/AI/NIAID NIH HHS/United States
- P30 CA 79458/CA/NCI NIH HHS/United States
- R01 AI 54232/AI/NIAID NIH HHS/United States
- R01 AI 56997/AI/NIAID NIH HHS/United States
- R01 DE 12934/DE/NIDCR NIH HHS/United States
- R37 AI 28246/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical